I reiterate a buy rating for Kuaishou Technology (KUASF) due to its strong position in the Chinese e-commerce industry and ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 annual results as of 31 December 2024.
Q4 2024 Earnings Call Transcript March 25, 2025 Operator: Good day, and welcome to the Noah Fourth Quarter and Full Year 2024 ...
Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical ...
SHANGHAI, March 27, 2025 (GLOBE NEWSWIRE) -- Jiayin Group Inc. ("Jiayin” or the "Company”) (NASDAQ: JFIN), a leading fintech ...
Apple CEO Tim Cook visited Zhejiang University for the 10th anniversary of the Mobile Application Innovation program, jointly ...
Chinese AI unicorn SenseTime reported a net loss of RMB 4.3 billion ($592 million) for the full year of 2024, exceeding ...
Apple CEO Tim Cook visits China, meeting with developers in Hangzhou and praising AI startup DeepSeek amid declining iPhone sales.
Solid Revenue Growth Coupled with High Gross Profit Margin (73%) and Non-IFRS Profit (RMB 376 Million) BEIJING, March 26, 2025 /PRNewswire/ -- Bairong Inc. (the "Company", "we", "us" or ...
1d
Vietnam Investment Review on MSNWuXi Biologics Posts Strong 2024 Results Forecasts Rapid Growth in 2025Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for ...
The analysis of this year’s March sessions of the National People’s Congress (NPC) and the State Council of the People’s Republic of China forms a coherent narrative of “controlled modernisation.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results